Aris Kekedjan

Aris Kekedjian is a seasoned investment and corporate executive with leadership experience across major global institutions. He previously served as Chairman and CEO of Trinity Biotech (Nasdaq: TRIB), a Dublin-based developer and manufacturer of diagnostic products for point-of-care and clinical laboratory markets. Previously, Kekedjian was President and CEO of Icahn Enterprises (Nasdaq: IEP), the diversified holding company of activist investor Carl Icahn. His career foundation spans nearly three decades at General Electric, where he rose to Chief Investment Officer and Global Head of Business Development. Aris holds a Bachelor of Commerce degree in Finance and International Business from Concordia University in Montreal, Canada.

Key Experience

C-Level Roles

• Chief Investment Officer and Global Head of Business Development, General Electric (NYSE: GE)

• Chairman and CEO of Trinity Biotech (Nasdaq: TRIB)

• CEO at Carl Icahn Holdings (NASDAQ: IEP)

Investment Partner